A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Interventional
Start Date: December 7, 2023
End Date: March 30, 2026
71 days until trial ends

Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU) (BEACON)

Interventional
Start Date: September 29, 2023
End Date: April 1, 2026
73 days until trial ends